Drug Maker Mallinckrodt Reaches $1.6B Settlement for Role in Opioid Crisis

Feb 26, 2020

A British pharmaceutical company has reached a tentative deal to settle hundreds of U.S. lawsuits over its role in fueling the opioid crisis. The generic drug manufacturer Mallinckrodt says the $1.6 billion deal has the support of attorneys general from 47 U.S. states and territories. Federal data show the company was a top producer of highly addictive prescription pain medication at the peak of the opioid crisis, shipping some 2.3 billion pills over an eight-year period beginning in 2006.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s